ArticleFrontiers in immunology2026
Identification and analysis of diagnostic senescence-related gene signatures for acute myocardial infarction based on multi-omics data and machine learning.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute myocardial infarction (AMI) incidence increases with population aging, alongside heightened cellular senescence; however, clinically useful senescence-related genes (SRGs) for AMI remain poorly defined. This study aimed to identify AMI-associated SRGs and develop multi-dimensional models for diagnostic evaluation and patient stratification. Methods: Transcriptomic datasets comprising 106 AMI patients and 76 controls were integrated for differential expression and weighted gene co-expression network analyses. An external independent validation cohort including 37 AMI cases and 15 controls was used for further evaluation. Four machine learning algorithms were applied to identify diagnostic SRGs. The selected genes were validated across bulk RNA-seq, single-cell RNA-seq, proteomic data, and mouse myocardial infarction models. Based on these genes, we constructed three SRG-based models: a diagnostic classifier, a patient stratification system, and a senescence scoring system. Results: Thirteen AMI-associated SRGs were identified, among which four genes, FOS, SOD2, MXD1, and GRN, showed consistent diagnostic relevance across datasets. The four-gene diagnostic model achieved an AUC of 0.808 and showed favorable clinical net benefit. Patient stratification identified a low-senescence group enriched in anti-inflammatory cells and a high-senescence group characterized by pro-inflammatory neutrophil infiltration. The senescence score showed a moderate positive correlation with neutrophil infiltration. Conclusion: This study identifies FOS, SOD2, MXD1, and GRN as candidate AMI-associated senescence-related biomarkers and establishes preliminary SRG-based models for AMI diagnosis and stratification. These findings suggest that neutrophil-enriched inflammatory responses are associated with senescence-related transcriptional features in AMI and provide a framework for future studies on senescence-related pathways in personalized AMI management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.